Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection

PK Drain, KL Bajema, D Dowdy, K Dheda… - Clinical microbiology …, 2018 - Am Soc Microbiol
Tuberculosis (TB) is the leading infectious cause of mortality worldwide, due in part to a
limited understanding of its clinical pathogenic spectrum of infection and disease …

[HTML][HTML] Human tuberculosis and Mycobacterium tuberculosis complex: A review on genetic diversity, pathogenesis and omics approaches in host biomarkers …

RD Kanabalan, LJ Lee, TY Lee, PP Chong… - Microbiological …, 2021 - Elsevier
Mycobacterium tuberculosis complex (MTBC) refers to a group of mycobacteria
encompassing nine members of closely related species that causes tuberculosis in animals …

Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers

RS Wallis, M Maeurer, P Mwaba, J Chakaya… - The Lancet infectious …, 2016 - thelancet.com
Tuberculosis is the leading infectious cause of death worldwide, with 9· 6 million cases and
1· 5 million deaths reported in 2014. WHO estimates 480 000 cases of these were multidrug …

Circulating microRNAs as potential biomarkers of infectious disease

CN Correia, NC Nalpas, KE McLoughlin… - Frontiers in …, 2017 - frontiersin.org
microRNAs (miRNAs) are a class of small non-coding endogenous RNA molecules that
regulate a wide range of biological processes by post-transcriptionally regulating gene …

Gene set enrichment for reproducible science: comparison of CERNO and eight other algorithms

J Zyla, M Marczyk, T Domaszewska… - …, 2019 - academic.oup.com
Motivation Analysis of gene set (GS) enrichment is an essential part of functional omics
studies. Here, we complement the established evaluation metrics of GS enrichment …

Tuberculosis biomarkers: from diagnosis to protection

D Goletti, E Petruccioli, SA Joosten… - Infectious disease …, 2016 - pmc.ncbi.nlm.nih.gov
New approaches to control tuberculosis (TB) worldwide are needed. In particular, new tools
for diagnosis and new biomarkers are required to evaluate both pathogen and host key …

[HTML][HTML] Comprehensive plasma proteomic profiling reveals biomarkers for active tuberculosis

DJ Garay-Baquero, CH White, NF Walker… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND Tuberculosis (TB) kills more people than any other infection, and new
diagnostic tests to identify active cases are required. We aimed to discover and verify novel …

Next-generation sequencing based HLA ty**: deciphering immunogenetic aspects of sarcoidosis

A Kishore, M Petrek - Frontiers in genetics, 2018 - frontiersin.org
Unraveling of the HLA-related immunogenetic basis of several immune disorders is complex
due to the extensive HLA polymorphism and strong linkage-disequilibrium between HLA …

From simple to complex: Protein‐based biomarker discovery in tuberculosis

Z Mousavian, G Källenius… - European Journal of …, 2023 - Wiley Online Library
Tuberculosis (TB) is a deadly infectious disease that affects millions of people globally. TB
proteomics signature discovery has been a rapidly growing area of research that aims to …

Vitamin D and the promoter methylation of its metabolic pathway genes in association with the risk and prognosis of tuberculosis

M Wang, W Kong, B He, Z Li, H Song, P Shi, J Wang - Clinical Epigenetics, 2018 - Springer
Background A variety of abnormalities in vitamin D metabolism have been reported in
patients with active tuberculosis. However, intervention trials have produced inconsistent …